Current Therapy of Drugs in Amyotrophic Lateral Sclerosis.

about

Lysophosphatidic acid and amitriptyline signal through LPA1R to reduce P-glycoprotein transport at the blood-brain barrier.

P2860

Q51032610-430365E0-7E87-49DB-8BEA-0FD90C83AE52

P2860

Current Therapy of Drugs in Amyotrophic Lateral Sclerosis.

Item

http://www.wikidata.org/entity/Q36925891

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Current Therapy of Drugs in Amyotrophic Lateral Sclerosis.

@en

type

Item

label

Current Therapy of Drugs in Amyotrophic Lateral Sclerosis.

@en

prefLabel

Current Therapy of Drugs in Amyotrophic Lateral Sclerosis.

@en

P1476

Current Therapy of Drugs in Amyotrophic Lateral Sclerosis.

@en

P2093

Haiyan Lu

http://www.w3.org/2001/XMLSchema#string

Wei Dong Le

http://www.w3.org/2001/XMLSchema#string

Xiao-Ping Wang

http://www.w3.org/2001/XMLSchema#string

Ya-Ying Xie

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Olesoxime, a cholesterol-like neuroprotectant for the potential treatment of amyotrophic lateral sclerosis

Recent progress in the discovery of small molecules for the treatment of amyotrophic lateral sclerosis (ALS)

Therapeutic neuroprotective agents for amyotrophic lateral sclerosis

Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials

No benefit from chronic lithium dosing in a sibling-matched, gender balanced, investigator-blinded trial using a standard mouse model of familial ALS

Molecular chaperone mediated late-stage neuroprotection in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis

The potential of GPNMB as novel neuroprotective factor in amyotrophic lateral sclerosis

Pyrimethamine decreases levels of SOD1 in leukocytes and cerebrospinal fluid of ALS patients: a phase I pilot study

A novel acylaminoimidazole derivative, WN1316, alleviates disease progression via suppression of glial inflammation in ALS mouse model

Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation

P304

314-321

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.2174/1570159X14666160120152423

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2016-01-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26786249

http://www.w3.org/2001/XMLSchema#string

P921

amyotrophic lateral sclerosis

P932

4876587

http://www.w3.org/2001/XMLSchema#string

Current Therapy of Drugs in Amyotrophic Lateral Sclerosis.

about

P2860

P2860

Current Therapy of Drugs in Amyotrophic Lateral Sclerosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P5008

P577

P698

P921

P932